Hepatitis E Virus Infection
2014 · Clinical Microbiology Reviews · 647 citations
https://doi.org/10.1128/cmr.00057-13
N
Nassim Kamar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
968
Papers
36.0K
Citations
94
h-index
491
i10-index
Nassim Kamar is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Renal Transplantation Outcomes and Treatments & Liver Disease and Transplantation & Hepatitis Viruses Studies and Epidemiology. The author has an h-index of 94, co-authored 823 publications.
ORCID: 0000-0003-1930-8964Papers by this author
worksEASL Clinical Practice Guidelines on hepatitis E virus infection
2018 · Journal of Hepatology · 621 citations
https://doi.org/10.1016/j.jhep.2018.03.005
Hepatitis E Virus Antibodies in Blood Donors, France
2011 · Emerging infectious diseases · 357 citations
https://doi.org/10.3201/eid1712.110371
Hepatitis E Virus and Neurologic Disorders
2011 · Emerging infectious diseases · 311 citations
https://doi.org/10.3201/eid1702.100856
Is COVID-19 infection more severe in kidney transplant recipients?
2020 · American Journal of Transplantation · 263 citations
https://doi.org/10.1111/ajt.16424
Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys
2012 · American Journal of Transplantation · 262 citations
https://doi.org/10.1111/j.1600-6143.2011.03914.x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat